1 Fang, Y., Zhou, J., Ding, X., Ling, G. & Yu, S. Pulmonary fibrosis in critical ill patients recovered from COVID-19 pneumonia: Preliminary experience. Am J Emerg Med, doi:10.1016/j.ajem.2020.05.120 (2020).
2 Puntmann, V. O. et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA cardiology, doi:10.1001/jamacardio.2020.3557 (2020).
3 Huang, L. et al. Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging. JACC. Cardiovascular imaging, doi:10.1016/j.jcmg.2020.05.004 (2020).
4 Li, J. et al. Olfactory Dysfunction in Recovered Coronavirus Disease 2019 (COVID-19) Patients. Movement disorders : official journal of the Movement Disorder Society 35, 1100-1101, doi:10.1002/mds.28172 (2020).
5 Ayres, J. S. A metabolic handbook for the COVID-19 pandemic. Nature metabolism 2, 572-585, doi:10.1038/s42255-020-0237-2 (2020).
6 Wu, Q. et al. Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection. Scientific reports 7, 9110, doi:10.1038/s41598-017-09536-z (2017).
7 Banoei, M. M. et al. Plasma metabolomics for the diagnosis and prognosis of H1N1 influenza pneumonia. Critical care (London, England) 21, 97, doi:10.1186/s13054-017-1672-7 (2017).
8 Fujiogi, M. et al. Respiratory viruses are associated with serum metabolome among infants hospitalized for bronchiolitis: A multicenter study. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, doi:10.1111/pai.13296 (2020).
9 Eisfeld, A. J. et al. Multi-platform 'Omics Analysis of Human Ebola Virus Disease Pathogenesis. Cell host & microbe 22, 817-829.e818, doi:10.1016/j.chom.2017.10.011 (2017).
10 Cui, L. et al. Serum metabolome changes in adult patients with severe dengue in the critical and recovery phases of dengue infection. PLoS neglected tropical diseases 12, e0006217, doi:10.1371/journal.pntd.0006217 (2018).
11 Song, J. W. et al. Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis. Cell metabolism 32, 188-202.e185, doi:10.1016/j.cmet.2020.06.016 (2020).
12 Wu, D. et al. Plasma metabolomic and lipidomic alterations associated with COVID-19. National Science Review 7, 1157-1168, doi:10.1093/nsr/nwaa086 (2020).
13 Shen, B. et al. Proteomic and Metabolomic Characterization of COVID-19 Patient Sera. Cell 182, 59-72.e15, doi:10.1016/j.cell.2020.05.032 (2020).
14 Jiang, H. et al. SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses. Nature communications 11, 3581, doi:10.1038/s41467-020-17488-8 (2020).
15 Wang, S. et al. Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study. Diabetologia 63, 2102-2111, doi:10.1007/s00125-020-05209-1 (2020).
16 Sun, Y. et al. Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience. Journal of autoimmunity 112, 102473, doi:10.1016/j.jaut.2020.102473 (2020).
17 Zhang, J., Lee, K., Ang, L., Leo, Y. & Young, B. Risk Factors of Severe Disease and Efficacy of Treatment in Patients Infected with COVID-19: A Systematic Review, Meta-Analysis and Meta-Regression Analysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, doi:10.1093/cid/ciaa576 (2020).
18 Liu, F. et al. CT quantification of pneumonia lesions in early days predicts progression to severe illness in a cohort of COVID-19 patients. Theranostics 10, 5613-5622, doi:10.7150/thno.45985 (2020).
19 Luo, P. et al. A Large-scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma. Hepatology (Baltimore, Md.) 67, 662-675, doi:10.1002/hep.29561 (2018).
20 Maddocks, O. D. et al. Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature 493, 542-546, doi:10.1038/nature11743 (2013).
21 Long, Q. X. et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nature medicine 26, 1200-1204, doi:10.1038/s41591-020-0965-6 (2020).
22 Wu, Z. & McGoogan, J. M. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. Jama 323, 1239-1242, doi:10.1001/jama.2020.2648 (2020).
23 Zuo, T. et al. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19. Gut, doi:10.1136/gutjnl-2020-322294 (2020).
24 Gu, S. et al. Alterations of the Gut Microbiota in Patients with COVID-19 or H1N1 Influenza. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, doi:10.1093/cid/ciaa709 (2020).
25 Agus, A., Planchais, J. & Sokol, H. Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. Cell host & microbe 23, 716-724, doi:10.1016/j.chom.2018.05.003 (2018).
26 Ridlon, J., Harris, S., Bhowmik, S., Kang, D. & Hylemon, P. Consequences of bile salt biotransformations by intestinal bacteria. Gut microbes 7, 22-39, doi:10.1080/19490976.2015.1127483 (2016).
27 Wahlström, A., Sayin, S., Marschall, H. & Bäckhed, F. Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism. Cell metabolism 24, 41-50, doi:10.1016/j.cmet.2016.05.005 (2016).
28 Thomas, C., Pellicciari, R., Pruzanski, M., Auwerx, J. & Schoonjans, K. Targeting bile-acid signalling for metabolic diseases. Nature reviews. Drug discovery 7, 678-693, doi:10.1038/nrd2619 (2008).
29 Chen, X. et al. The microbial coinfection in COVID-19. Applied microbiology and biotechnology 104, 7777-7785, doi:10.1007/s00253-020-10814-6 (2020).
30 Zhang, G. et al. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 127, 104364, doi:10.1016/j.jcv.2020.104364 (2020).
31 Wingfield, B. D. et al. IMA Genome-F 9: Draft genome sequence of Annulohypoxylon stygium, Aspergillus mulundensis, Berkeleyomyces basicola (syn. Thielaviopsis basicola), Ceratocystis smalleyi, two Cercospora beticola strains, Coleophoma cylindrospora, Fusarium fracticaudum, Phialophora cf. hyalina, and Morchella septimelata. IMA fungus 9, 199-223, doi:10.5598/imafungus.2018.09.01.13 (2018).
32 Gao, J. et al. Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism. Frontiers in cellular and infection microbiology 8, 13, doi:10.3389/fcimb.2018.00013 (2018).
33 Zuccato, E. et al. Role of bile acids and metabolic activity of colonic bacteria in increased risk of colon cancer after cholecystectomy. Digestive diseases and sciences 38, 514-519, doi:10.1007/bf01316508 (1993).
34 Pai, A. B. et al. Lipoteichoic acid from Staphylococcus aureus induces lung endothelial cell barrier dysfunction: role of reactive oxygen and nitrogen species. PloS one 7, e49209, doi:10.1371/journal.pone.0049209 (2012).
35 Lai, Y. L., Chiou, W. Y., Lu, F. J. & Chiang, L. Y. Roles of oxygen radicals and elastase in citric acid-induced airway constriction of guinea-pigs. British journal of pharmacology 126, 778-784, doi:10.1038/sj.bjp.0702352 (1999).
36 Chen, Y. F. et al. Exchange protein directly activated by cAMP (Epac) protects against airway inflammation and airway remodeling in asthmatic mice. Respiratory research 20, 285, doi:10.1186/s12931-019-1260-2 (2019).
37 Wang, M. et al. Adenosine A(2B) receptor activation stimulates alveolar fluid clearance through alveolar epithelial sodium channel via cAMP pathway in endotoxin-induced lung injury. American journal of physiology. Lung cellular and molecular physiology 318, L787-l800, doi:10.1152/ajplung.00195.2019 (2020).
38 Xicoy, H., Wieringa, B. & Martens, G. J. M. The Role of Lipids in Parkinson's Disease. Cells 8, doi:10.3390/cells8010027 (2019).
39 Cheng, M. L. et al. Metabolic disturbances identified in plasma are associated with outcomes in patients with heart failure: diagnostic and prognostic value of metabolomics. Journal of the American College of Cardiology 65, 1509-1520, doi:10.1016/j.jacc.2015.02.018 (2015).
40 Rowland, A., Miners, J. & Mackenzie, P. The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification. The international journal of biochemistry & cell biology 45, 1121-1132, doi:10.1016/j.biocel.2013.02.019 (2013).
41 Gabarre, P. et al. Acute kidney injury in critically ill patients with COVID-19. Intensive Care Med 46, 1339-1348, doi:10.1007/s00134-020-06153-9 (2020).
42 Hallan, S. et al. Metabolomics and Gene Expression Analysis Reveal Down-regulation of the Citric Acid (TCA) Cycle in Non-diabetic CKD Patients. 26, 68-77, doi:10.1016/j.ebiom.2017.10.027 (2017).
43 Tan, S. et al. Complement C5a Induces Renal Injury in Diabetic Kidney Disease by Disrupting Mitochondrial Metabolic Agility. 69, 83-98, doi:10.2337/db19-0043 (2020).
44 Naquet, P., Kerr, E., Vickers, S. & Leonardi, R. J. P. i. l. r. Regulation of coenzyme A levels by degradation: the 'Ins and Outs'. 78, 101028, doi:10.1016/j.plipres.2020.101028 (2020).
45 Duranton, F. et al. Normal and pathologic concentrations of uremic toxins. 23, 1258-1270, doi:10.1681/asn.2011121175 (2012).
46 Ping, F. et al. Metabolomics Analysis of the Renal Cortex in Rats With Acute Kidney Injury Induced by Sepsis. 6, 152, doi:10.3389/fmolb.2019.00152 (2019).
47 Netea, M. G. et al. Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection. Cell 181, 969-977, doi:10.1016/j.cell.2020.04.042 (2020).
48 Gibson, C. & Berliner, N. How we evaluate and treat neutropenia in adults. Blood 124, 1251-1258; quiz 1378, doi:10.1182/blood-2014-02-482612 (2014).
49 Jakaria, M. et al. Taurine and its analogs in neurological disorders: Focus on therapeutic potential and molecular mechanisms. Redox biology 24, 101223, doi:10.1016/j.redox.2019.101223 (2019).
50 Sun, Q. et al. Taurine Supplementation Lowers Blood Pressure and Improves Vascular Function in Prehypertension: Randomized, Double-Blind, Placebo-Controlled Study. Hypertension (Dallas, Tex. : 1979) 67, 541-549, doi:10.1161/hypertensionaha.115.06624 (2016).
51 Murakami, S. et al. Prevention of neointima formation by taurine ingestion after carotid balloon injury. Vascular pharmacology 53, 177-184, doi:10.1016/j.vph.2010.07.003 (2010).
52 Zulli, A. et al. High dietary taurine reduces apoptosis and atherosclerosis in the left main coronary artery: association with reduced CCAAT/enhancer binding protein homologous protein and total plasma homocysteine but not lipidemia. Hypertension (Dallas, Tex. : 1979) 53, 1017-1022, doi:10.1161/hypertensionaha.109.129924 (2009).
53 Ito, T. et al. Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy. Journal of molecular and cellular cardiology 44, 927-937, doi:10.1016/j.yjmcc.2008.03.001 (2008).
54 L'Amoreaux, W. J. et al. Taurine regulates insulin release from pancreatic beta cell lines. Journal of biomedical science 17 Suppl 1, S11, doi:10.1186/1423-0127-17-s1-s11 (2010).
55 Angajala, A. et al. Diverse Roles of Mitochondria in Immune Responses: Novel Insights Into Immuno-Metabolism. Front Immunol 9, 1605, doi:10.3389/fimmu.2018.01605 (2018).
56 Zeisel, S. H. Choline: an essential nutrient for humans. Nutrition (Burbank, Los Angeles County, Calif.) 16, 669-671, doi:10.1016/s0899-9007(00)00349-x (2000).
57 Zeisel, S. H. & Blusztajn, J. K. Choline and human nutrition. Annual review of nutrition 14, 269-296, doi:10.1146/annurev.nu.14.070194.001413 (1994).
58 Roe, A. J. et al. Choline and its metabolites are differently associated with cardiometabolic risk factors, history of cardiovascular disease, and MRI-documented cerebrovascular disease in older adults. The American journal of clinical nutrition 105, 1283-1290, doi:10.3945/ajcn.116.137158 (2017).
59 Guan, W. J. et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. The European respiratory journal 55, doi:10.1183/13993003.00547-2020 (2020).
60 Yang, J. J. et al. Associations of choline-related nutrients with cardiometabolic and all-cause mortality: results from 3 prospective cohort studies of blacks, whites, and Chinese. The American journal of clinical nutrition 111, 644-656, doi:10.1093/ajcn/nqz318 (2020).
61 Floegel, A. et al. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 62, 639-648, doi:10.2337/db12-0495 (2013).
62 Zhu, L. et al. Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes. Cell metabolism 31, 1068-1077.e1063, doi:10.1016/j.cmet.2020.04.021 (2020).
63 Tzoulaki, I. et al. Serum metabolic signatures of coronary and carotid atherosclerosis and subsequent cardiovascular disease. European heart journal 40, 2883-2896, doi:10.1093/eurheartj/ehz235 (2019).
64 Hansell, D. M. et al. Fleischner Society: glossary of terms for thoracic imaging. Radiology 246, 697-722, doi:10.1148/radiol.2462070712 (2008).
65 Shi, H. et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. The Lancet Infectious Diseases 20, 425-434, doi:10.1016/s1473-3099(20)30086-4 (2020).
66 Smilde, A. K., van der Werf, M. J., Bijlsma, S., van der Werff-van der Vat, B. J. & Jellema, R. H. Fusion of mass spectrometry-based metabolomics data. Analytical chemistry 77, 6729-6736, doi:10.1021/ac051080y (2005).
67 Dunn, W. B. et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nature protocols 6, 1060-1083, doi:10.1038/nprot.2011.335 (2011).
68 Luo, P. et al. Metabolic characteristics of large and small extracellular vesicles from pleural effusion reveal biomarker candidates for the diagnosis of tuberculosis and malignancy. Journal of Extracellular Vesicles 9, 1790158, doi:10.1080/20013078.2020.1790158 (2020).